Advertisement
New Zealand markets closed

  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     

  • NZD/USD

    0.5943
    -0.0007 (-0.11%)
     

  • NZD/EUR

    0.5552
    +0.0012 (+0.22%)
     

  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     

  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     

  • OIL

    83.69
    +0.12 (+0.14%)
     

  • GOLD

    2,350.80
    +8.30 (+0.35%)
     

  • NASDAQ

    17,718.30
    +287.79 (+1.65%)
     

  • FTSE

    8,139.83
    +60.97 (+0.75%)
     

  • Dow Jones

    38,239.66
    +153.86 (+0.40%)
     

  • DAX

    18,161.01
    +243.73 (+1.36%)
     

  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • NZD/JPY

    93.7910
    +1.2950 (+1.40%)
     

Company News for Sep 27, 2021

Zacks Equity Research
·1-min read

  • Meredith Corporation’s MDP shares jumped 25.4% after reports suggested that the company is in advanced talks with IAC/InterActiveCorp that will acquire it in a deal valued at over $2.5 billion.

  • Shares of vTv Therapeutics Inc. VTVT rose 3.4% after the company disclosed results of multiple ascending dose study and development plan for HPP737, for the treatment of psoriasis.

  • Marin Software Incorporated’s MRIN shares surged 19.6% after the company announced a revenue share agreement with Google.

  • Shares of Costco Wholesale Corporation COST jumped 3.3% after the company reported that it topped $60 billion in net sales in a single quarter for the first time and hit $5 billion in annual profit, growing at its fastest pace in more than 20 years.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Meredith Corporation (MDP): Free Stock Analysis Report
 
Costco Wholesale Corporation (COST) : Free Stock Analysis Report
 
Marin Software Incorporated (MRIN) : Free Stock Analysis Report
 
vTv Therapeutics Inc. (VTVT) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research